Summit Therapeutics, Inc. (SMMT)
17.33
+0.33
(+1.94%)
USD |
NASDAQ |
May 27, 16:00
17.33
0.00 (0.00%)
After-Hours: 17:28
Summit Therapeutics Cash from Investing (Quarterly) : -0.238M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 172.62M |
| BioMarin Pharmaceutical, Inc. | 725.53M |
| Merck & Co., Inc. | -10.21B |
| Denali Therapeutics, Inc. | 94.46M |
| Relay Therapeutics, Inc. | 32.90M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -122.29M |
| Cash from Financing (Quarterly) | 3.797M |
| Free Cash Flow | -387.48M |
| Free Cash Flow Per Share (Quarterly) | -0.158 |
| Free Cash Flow to Equity (Quarterly) | -121.68M |
| Free Cash Flow to Firm (Quarterly) | -122.54M |
| Free Cash Flow Yield | -2.95% |